AR009600A1 - SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME. - Google Patents

SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME.

Info

Publication number
AR009600A1
AR009600A1 ARP970105002A ARP970105002A AR009600A1 AR 009600 A1 AR009600 A1 AR 009600A1 AR P970105002 A ARP970105002 A AR P970105002A AR P970105002 A ARP970105002 A AR P970105002A AR 009600 A1 AR009600 A1 AR 009600A1
Authority
AR
Argentina
Prior art keywords
sequence
vaccine compositions
nucleic acid
amino acids
same
Prior art date
Application number
ARP970105002A
Other languages
Spanish (es)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR009600A1 publication Critical patent/AR009600A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Abstract

Se describen preparaciones recombinantes o sustancialmente puras de polipéptidos de H.pylori. Los ácidos nucleicos que codifican a lospolipéptidos también se describen. Los polipéptidos de H.pylori son utiles para el diagnotico y lascom posiciones para vacuna.Recombinant or substantially pure preparations of H.pylori polypeptides are described. Nucleic acids encoding polypeptides are also described. H.pylori polypeptides are useful for diagnosis and vaccine compositions.

ARP970105002A 1996-10-28 1997-10-28 SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME. AR009600A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73915096A 1996-10-28 1996-10-28
US75973996A 1996-12-06 1996-12-06
US89192897A 1997-07-14 1997-07-14

Publications (1)

Publication Number Publication Date
AR009600A1 true AR009600A1 (en) 2000-04-26

Family

ID=27419246

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970105002A AR009600A1 (en) 1996-10-28 1997-10-28 SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME.

Country Status (19)

Country Link
EP (1) EP0973394A4 (en)
JP (1) JP2001504329A (en)
KR (1) KR20000052831A (en)
CN (1) CN1235513A (en)
AR (1) AR009600A1 (en)
AU (1) AU734052B2 (en)
BR (1) BR9712587A (en)
CA (1) CA2265523A1 (en)
EE (1) EE9900176A (en)
ID (1) ID22065A (en)
IL (1) IL129397A0 (en)
IS (1) IS5005A (en)
NO (1) NO991995L (en)
NZ (1) NZ334568A (en)
PL (1) PL333169A1 (en)
SA (1) SA98180918A (en)
SK (1) SK34699A3 (en)
TR (1) TR199900940T2 (en)
WO (1) WO1998018323A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003824A1 (en) * 1993-07-27 1995-02-09 Csl Limited Treatment of h. pylori associated gastroduodenal disease
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
DE19730425A1 (en) 1997-07-16 1999-01-21 Henkel Teroson Gmbh Heat-curing laundry-resistant shell sealant
WO2000006743A2 (en) * 1998-07-27 2000-02-10 Connaught Laboratories Limited Chlamydia antigens and corresponding dna fragments and uses thereof
SE9901548D0 (en) * 1999-04-29 1999-04-29 Astra Ab Helicobacter pylori antigens
GB9914945D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Biolog Novel compounds
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
CN101532001A (en) 2000-03-08 2009-09-16 诺维信公司 Variants with altered properties
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
GB0010370D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
US9359627B2 (en) 2011-03-17 2016-06-07 National University Corporation Mie University Antibody production method
US10828358B2 (en) * 2015-12-14 2020-11-10 Technische Universität München Helicobacter pylori vaccines
CN115724922B (en) * 2022-07-19 2023-08-22 四川大学华西医院 Helicobacter pylori vaccine recombinant protein antigen TonB, preparation method and application thereof
CN115581201A (en) * 2022-08-26 2023-01-10 云南省农业科学院花卉研究所 Diploid rose F induced by stem segment as explant 1 -61 plant regeneration method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (en) * 1993-01-19 1994-07-20 Medicarb Ab Preparation of a new drug

Also Published As

Publication number Publication date
TR199900940T2 (en) 1999-09-21
EP0973394A1 (en) 2000-01-26
AU734052B2 (en) 2001-05-31
JP2001504329A (en) 2001-04-03
KR20000052831A (en) 2000-08-25
IL129397A0 (en) 2000-02-17
EP0973394A4 (en) 2005-03-30
NZ334568A (en) 2000-04-28
BR9712587A (en) 1999-10-26
CA2265523A1 (en) 1998-05-07
NO991995D0 (en) 1999-04-27
EE9900176A (en) 1999-12-15
SA98180918A (en) 2005-12-03
AU5093398A (en) 1998-05-22
PL333169A1 (en) 1999-11-22
NO991995L (en) 1999-06-28
WO1998018323A1 (en) 1998-05-07
SK34699A3 (en) 2000-04-10
ID22065A (en) 1999-08-26
IS5005A (en) 1999-03-18
CN1235513A (en) 1999-11-17

Similar Documents

Publication Publication Date Title
AR009600A1 (en) SEQUENCE OF NUCLEIC ACID AND AMINO ACIDS RELATED TO HELICOBACTER PYLORI AND VACCINE COMPOSITIONS OF THE SAME.
EP0722461A4 (en) Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
AR004668A1 (en) A PURIFIED ISOLATED NUCLEIC ACID, A RECOMBINING VECTOR OF EXPRESSION THAT UNDERSTANDS IT, A CELL THAT INCLUDES SUCH A VECTOR, A METHOD FOR THE PRODUCTION OF A H.PYLORI POLYPEPTIDE, A COMPOSITION OF A VACCINE, A PREPARED COMPOSITION PURIFIED BY H.
AR067658A2 (en) AN IMMUNOGENIC POLYPEPTIDE, A POLINUCLEOTIDE CODIFYING THEM, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE POLYPEPTIDES AND POLYNUCLEOTIDES, XPRESSION VECTORS, VACCINES, A METHOD FOR THE PREPARATION OF SUCH POLYPEPTIDE DIFFUSED POLIPEPTIDE.
KR870700019A (en) Recombinant alveolar surfactant protein
ATE108438T1 (en) URETHANE PROTECTED AMINO ACIDS N- CARBOXYAN HYDRIDES.
BR9306272A (en) Peptide and pharmaceutical composition
NZ332565A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
AR013618A1 (en) METHOD AND COMPOSITIONS FOR THE DISTRIBUTION AND EXPRESSION OF NUCLEIC ACIDS OF INTERFERON
DK0463053T3 (en) Preparation and use of anthelmintic agents and protective immunogens
NO992158L (en) Nucleic acid and amino acid sequences associated with Heliobacter Pylori and vaccine preparations thereof.
DE3650035T2 (en) THF compositions.
DK527187A (en) GONADOLIBERINE ANALOGUE, PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
DE3686257D1 (en) PRODUCTION OF POLYPEPTIDES.
DK1612555T3 (en) Cryptic peptides for use in inducing immunological tolerance
MX9709846A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics.
ID23052A (en) VACCINE COMPOSITION THAT CONTAINS POLYPEPTIDE OF FLGE HELICOBACTER PYLORI
TH43867A (en) Nucleic acid sequence and amino acids associated with Helicobacter pyroli and their vaccine composition.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal